Development of Biomaterials for Feeder-Free and Xeno-Free Culture of Human Pluripotent Stem (Es and Ips) Cells(3/3)

Keyphrases

1. Human Pluripotent Stem Cells (hPSCs) 100%
2. Biomaterials 91%
3. Pluripotent Stem Cell Culture 53%
4. Cell Culture 52%
5. Induced Pluripotent Stem Cells (iPSCs) 52%
6. Oligopeptides 51%
7. Stem Cell Culture 50%
8. Physical Cues 50%
9. Culture Material 41%
10. Xeno-free Conditions 36%
11. Human Embryonic Stem Cells (hESCs) 35%
12. Embryonic Stem Cells 35%
13. Pluripotent Stem Cells 34%
14. Stem Cells 34%
15. Polyvinyl Alcohol Hydrogel 33%
16. Genomic Plasticity 33%
17. Varying Stiffness 33%
18. Polyvinyl Alcohol 33%
19. Genetic Material 33%
20. Vision Loss 33%
21. Stem Cell Therapy 33%
22. Itaconic Acid 33%
23. Retinal pigment Epithelium 33%
24. Pluripotent 30%
25. Mycobacterium Tuberculosis (M. tb) 26%
26. Clinical Trials 26%
27. Xeno-free Culture 25%
28. Stiffness 25%
29. Extracellular Matrix 20%
30. Macular Degeneration 20%
31. Stem Cell-derived 20%
32. Feeder-free 16%
33. Human ESCs 16%
34. Free-free 16%
35. Stiffness Properties 16%
36. Polyacrylamide (PAAm) 16%
37. Adipose-derived Stem Cells 15%
38. Cell-based 14%
39. Stem Cell Fate 13%
40. Stem Cell Differentiation 13%
41. Human-to-human 13%
42. Human iPSC 13%
43. Long-term Persistence 13%
44. Mesenchymal Stem Cells 13%
45. Host Tissues 13%
46. Human Genes 13%
47. Culture Conditions 9%
48. Nanosegments 8%
49. Surface Manipulation 8%
50. Stem Cell Lines 8%
51. Polyacrylamide Hydrogel 8%
52. Crosslinking Time 8%
53. Modified Substrate 8%
54. Superior Performance 8%
55. Bioinert 8%
56. Crosslinking Degree 8%
57. Amniotic Fluid Stem Cells 8%
58. Free Transport 6%
59. Stem Cell Clinics 6%
60. Isolated Tissue 6%
61. Bacterial Genetics 6%
62. Therapeutic Failure 6%
63. Prolonged Therapy 6%
64. Pluripotent Stem Cell Differentiation 6%
65. Immunologic Therapy 6%
66. Host Microenvironment 6%
67. Tuberculosis Infection 6%
68. Host Immunity 6%
69. Host DNA 6%
70. Cell-to-cell 6%
71. Pore Size 6%
72. Degenerative Disease 6%
73. Biocompatibility 6%
74. Tuberculosis 6%
75. Cell Suspension 6%
76. Circuitry 6%
77. Synthetic Biomaterials 6%
78. Recent Advances 6%
79. Polymeric Layer 6%
80. New Evidence 6%
81. Natural Biomaterials 6%
82. Bacterial Cells 6%
83. Mechanical Force 6%
84. Transplantation 6%
85. Fetal Stem Cells 6%
86. Chemotherapy Resistance 6%
87. Immunogenic 6%
88. Bruch's Membrane 6%
89. Disease Treatment 6%
90. Microbes 6%
91. Gene Methylation 6%
92. Human-induced 6%
93. Bone Marrow Mononuclear Cells 6%
94. Differentiated Cells 6%
95. Adult Stem Cells 6%
96. Next-generation Vaccines 6%
97. Three Germ Layers 6%
98. DNA Sequencing 6%
99. Survival Mechanism 6%
100. Cellular DNA 6%
101. Negative Effects 6%
102. Targeted Treatment 6%
103. Cell Death 6%
104. New Drugs 6%
105. Immune Cells 6%
106. Cell Division 6%
107. Polymeric Membrane 6%
108. Bone Marrow 6%
109. Epigenetics 6%
110. Small Molecules 6%
111. Bioengineering Techniques 6%
112. Water Molecule 6%
113. Age-related Macular Degeneration 6%
114. Host Immune Response 6%
115. Cell Sheet 6%
116. Electrical Stimulation 6%
117. Cell Differentiation 5%
118. Cell Attachment 5%
119. Cell Proliferation 5%
120. Physical Characteristics 5%
121. Human Hematopoietic Stem Cells 5%